Search Results - "Bruin, S."

The use of remote sensing in soil and terrain mapping — A review by Mulder, V.L., de Bruin, S., Schaepman, M.E., Mayr, T.R.

“…This article reviews the use of optical and microwave remote sensing data for soil and terrain mapping with emphasis on applications at regional and coarser…”
Get full text

Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry by Ariëns, Lieneke F. M., Schaft, Jorien, Bakker, Daphne S., Balak, Deepak, Romeijn, Margreet L. E., Kouwenhoven, Tessa, Kamsteeg, Marijke, Giovannone, Barbara, Drylewicz, Julia, Amerongen, Cynthia Catalina Aurora, Delemarre, Evelien M., Knol, Edward F., Wijk, Femke, Nierkens, Stefan, Thijs, Judith L., Schuttelaar, Marie L. A., Bruin‐Weller, Marjolein S.

“…Introduction Dupilumab has recently been approved for the treatment of moderate to severe atopic dermatitis (AD) in adults. Daily practice data on dupilumab…”
Get full text

Dupilumab has a profound effect on specific‐IgE levels of several food allergens in atopic dermatitis patients by Spekhorst, Lotte S., Rijst, Lisa P., Graaf, Marlies, Megen, Maxime, Zuithoff, Nicolaas P. A., Knulst, André C., Bruin‐Weller, Marjolein S., Le, Thuy‐My

Get full text

Towards operational validation of annual global land cover maps by Tsendbazar, N., Herold, M., Li, L., Tarko, A., de Bruin, S., Masiliunas, D., Lesiv, M., Fritz, S., Buchhorn, M., Smets, B., Van De Kerchove, R., Duerauer, M.

“…Annual global land cover maps (GLC) are being provided by several operational monitoring efforts. However, map validation is lagging, in the sense that the…”
Get full text

Assessing global land cover reference datasets for different user communities by Tsendbazar, N.E., de Bruin, S., Herold, M.

“…Global land cover (GLC) maps and assessments of their accuracy provide important information for different user communities. To date, there are several GLC…”
Get full text

Sensitivity and Specificity of 50% Excess Weight Loss (50%EWL) and Twelve Other Bariatric Criteria for Weight Loss Success by van de Laar, Arnold W., van Rijswijk, A. S., Kakar, H., Bruin, S. C.

“…Background Criteria for bariatric weight loss success are numerous. Most of them are arbitrary. None of them is evidence-based. Our objective was to determine…”
Get full text

Developing and applying a multi-purpose land cover validation dataset for Africa by Tsendbazar, N-E., Herold, M., de Bruin, S., Lesiv, M., Fritz, S., Van De Kerchove, R., Buchhorn, M., Duerauer, M., Szantoi, Z., Pekel, J.-F.

“…The production of global land cover products has accelerated significantly over the past decade thanks to the availability of higher spatial and temporal…”
Get full text

The long‐term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis—52 week results from the Dutch BioDay Registry by Voorberg, Angelique N., Romeijn, Geertruida L. E., Bruin‐Weller, Marjolein S., Schuttelaar, Marie L. A.

“…Background The hands are a common predilection site of atopic dermatitis (AD). Dupilumab is licensed for the treatment of AD but not for chronic hand eczema…”
Get full text

Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis by Spekhorst, Lotte S., Bakker, Daphne, Drylewicz, Julia, Rispens, Theo, Loeff, Floris, Boesjes, Celeste M., Thijs, Judith, Romeijn, Geertruida L. E., Loman, Laura, Schuttelaar, Marie‐Louise, Wijk, Femke, Graaf, Marlies, Bruin‐Weller, Marjolein S.

“…Background At present, no real‐world studies are available on different dupilumab dosing regimens in controlled atopic dermatitis (AD). The aim of this study…”
Get full text

Microbiome-derived ethanol in nonalcoholic fatty liver disease by Meijnikman, Abraham S., Davids, Mark, Herrema, Hilde, Aydin, Omrum, Tremaroli, Valentina, Rios-Morales, Melany, Levels, Han, Bruin, Sjoerd, de Brauw, Maurits, Verheij, Joanne, Kemper, Marleen, Holleboom, Adriaan G., Tushuizen, Maarten E., Schwartz, Thue W., Nielsen, Jens, Brandjes, Dees, Dirinck, Eveline, Weyler, Jonas, Verrijken, An, De Block, Christophe E. M., Vonghia, Luisa, Francque, Sven, Beuers, Ulrich, Gerdes, Victor E. A., Bäckhed, Fredrik, Groen, Albert K., Nieuwdorp, Max

“…To test the hypothesis that the gut microbiota of individuals with nonalcoholic fatty liver disease (NAFLD) produce enough ethanol to be a driving force in the…”
Get full text

Ocular surface disease is common in moderate‐to‐severe atopic dermatitis patients by Achten, Roselie E., Bakker, Daphne S., Luijk, Chantal M., Wal, Marlot, Graaf, Marlies, Wijk, Femke, Zuithoff, Nicolaas P.A., Rijst, Lisa P., Boesjes, Celeste M., Thijs, Judith L., Boer, Joke H., Bruin‐Weller, Marjolein S.

Get full text

Differential dynamics of TARC during JAK‐inhibitor therapy compared to biological therapies targeting type 2 inflammation by Boesjes, Celeste M., Bakker, Daphne S., Knol, Edward F., Graaf, Marlies, Wijk, Femke, Bruin‐Weller, Marjolein S.

Get full text

What users of global risk indicators should know by Visser, H., de Bruin, S., Martens, A., Knoop, J., Ligtvoet, W.

“…•The number of global-risk related data has grown immensely over recent decades.•Users of risk data should be alert that the reliability is unclear in many…”
Get full text

The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: A comparative study by Hompes, D., D'Hoore, A., Wolthuis, A., Fieuws, S., Mirck, B., Bruin, S., Verwaal, V.

“…Background Oxaliplatin and Mitomycin C (MMC) are both suitable as intraperitoneal chemotherapy agents in HIPEC for peritoneal carcinomatosis (PC) of colorectal…”
Get full text

EASI p‐EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers by Bakker, Daphne S., Ariens, Lieneke F. M., Giovannone, Barbara, Hijnen, DirkJan, Delemarre, Eveline M., Knol, Edward, Nierkens, Stefan, Bruin‐Weller, Marjolein S., Thijs, Judith L., Drylewicz, Julia

Get full text

A meta‐analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis by Meeberg, Maartje M., Hebing, Renske C. F., Nurmohamed, Michael T., Fidder, Herma H., Heymans, Martijn W., Bouma, Gerd, Bruin‐Weller, Marjolein S., Tekstra, Janneke, Bemt, Bart, Jonge, Robert, Bulatović Ćalasan, Maja

“…Aims In immune‐mediated inflammatory diseases (IMIDs), early symptom control is a key therapeutic goal. Methotrexate (MTX) is the first‐line treatment across…”
Get full text

Muscle and joint pain during dupilumab treatment for atopic dermatitis: Lack of association with antinuclear antibodies by Boesjes, Celeste M., Emst, Madelon, Bakker, Daphne S., Spekhorst, Lotte S., Wijk, Femke, Graaf, Marlies, Bruin‐Weller, Marjolein S.

Get full text

European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2) infection and atopic dermatitis by Wollenberg, A., Flohr, C., Simon, D., Cork, M.J., Thyssen, J.P., Bieber, T., Bruin‐Weller, M.S., Weidinger, S., Deleuran, M., Taieb, A., Paul, C., Trzeciak, M., Werfel, T., Seneschal, J., Barbarot, S., Darsow, U., Torrelo, A., Stalder, J.‐F., Svensson, Å., Hijnen, D., Gelmetti, C., Szalai, Z., Gieler, U., De Raeve, L., Kunz, B., Spuls, P., Kobyletzki, L.B., Fölster‐Holst, R., Chernyshov, P.V., Christen‐Zaech, S., Heratizadeh, A., Ring, J., Vestergaard, C.

“…Atopic dermatitis (AD) is a complex disease with elevated risk of respiratory comorbidities.1,2 Severely affected patients are often treated with…”
Get full text

Data use and effectiveness in electronic surveillance of healthcare associated infections in the 21st century: a systematic review by de Bruin, Jeroen S, Seeling, Walter, Schuh, Christian

“…As more electronic health records have become available during the last decade, we aimed to uncover recent trends in use of electronically available patient…”
Get full text

Distinct differences in gut microbial composition and functional potential from lean to morbidly obese subjects by Meijnikman, A. S., Aydin, O., Prodan, A., Tremaroli, V., Herrema, H., Levin, E., Acherman, Y., Bruin, S., Gerdes, V.E., Backhed, F., Groen, A.K., Nieuwdorp, M.

“…Introduction The gut microbiome may contribute to the development of obesity. So far, the extent of microbiome variation in people with obesity has not been…”
Get full text